Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Vancouver, B.C., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the “Company”) announced that on Thursday, February 13, 2020, the Supreme...
Vancouver, B.C., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Vancouver, BC, January 3, 2020 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) further to...
Vancouver, B.C., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 16, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased...
Vancouver, B.C., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 13, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced...
Vancouver, B.C., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, December 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced...
Vancouver, B.C., Dec. 02, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that Trevor Dixon is returning to...
Vancouver, B.C., Nov. 25, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the...
Vancouver, B.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and...
Vancouver, B.C., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Vancouver, B.C., October 23, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) The...
Vancouver, B.C., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Vancouver, BC, October 17, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.05 | 0.05 | 0.05 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.05 | 0.05 | 0.05 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.05 | 0.05 | 0.05 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.05 | 0.05 | 0.05 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.05 | 0.05 | 0.05 | 0 | 0 | CS |
| 156 | 0 | 0 | 0.05 | 0.05 | 0.05 | 0 | 0 | CS |
| 260 | -0.055 | -52.380952381 | 0.105 | 0.19 | 0.03 | 11412 | 0.06681188 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
